메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Shimadzu Asia Pacific Celebrates 150th Anniversary -A Century and a Half of Driving Healthcare and Technological Breakthroughs

SINGAPORE, Oct. 21, 2025 -- Shimadzu Asia Pacific joins the global celebration of Shimadzu Corporation's 150th anniversary, marking a century and a half of pioneering innovations that have shaped science, technology, and healthcare worldwide. "As we celebrate 150 Years of Innovation, we remain committed to contributing to society through science and technology. Together with our partners, customers, and employees, we will continue developing solutions that address key challenges and create value across Asia Pacific and beyond," said Prem Anand, Managing Direct
- 김갑성 기자
- 2025-10-21 09:00
NSG Bio Launches NSG BioSuites at Geneo - A New Product, Largest Site, and Fourth Location in Singapore

SINGAPORE, Oct. 21, 2025 -- NSG Bio, a leading provider of flexible and high-quality biotech laboratory spaces, announced the launch of its latest product, NSG BioSuites, located at the brand-new Geneo development in Singapore Science Park. This marks NSG Bio's fourth site in Singapore and also its largest facility to date, representing a significant step forward in providing innovative, accessible solutions for the biotech community. NSG BioSuites is the company's newest offering: small to large, affordable private lab suites purpose-built for biotech teams ready
- 김갑성 기자
- 2025-10-21 08:00
LabConnect Featured in Season Finale of Emmy-Nominated Series Tomorrow's World Today

JOHNSON CITY, Tenn., Oct. 21, 2025 -- LabConnect, a leading provider of global central laboratory and support services for clinical trials, will be featured on the season 9 finale of the innovation-focused TV series, Tomorrow's World Today. Premiering on Science Channel on November 8, the episode explores how LabConnect is redefining clinical trial support as a technology-first partner for pharma and biotech. Tomorrow's World Today is an Emmy-nominated and Telly Award winning series exploring the latest advancements in science, sustainability, innovation, and technology. Airing
- 김갑성 기자
- 2025-10-21 01:11
Benchling Partners with Anthropic to Build a Bridge Between Science and AI

Claude's Life Sciences Ecosystem pairs Benchling AI with advanced reasoning in Claude SAN FRANCISCO, Oct. 21, 2025 -- Benchling today announced a partnership with Anthropic, an AI safety and research company and the creator of Claude, to advance AI in biotech through the Claude for Life Sciences Ecosystem. The collaboration pairs Benchling's trusted data foundation and AI agents with Claude's advanced reasoning capabilities. Scientists can now ask Claude questions about their Benchling data to get clear, source-linked answers, summaries, and decision-ready reports in minutes. B
- 김갑성 기자
- 2025-10-21 00:00
TraceLink Recognized on Fast Company's Next Big Things in Tech List

The annual list honors groundbreaking advancements redefining the way we work and live BOSTON, Oct. 20, 2025 -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, today announced its inclusion in Fast Company's Next Big Things in Tech list in the Enduring Impact category. This prestigious recognition highlights emerging technologies that have the potential to profoundly impact industries—from education and sustainability to robotics and artificial intelligence. The Enduring Impact category honors tech breakthroughs from
- 김갑성 기자
- 2025-10-20 23:59
WellsCare Partners with Celltrion Canada to Bring Advanced Wearable Pain Relief Tech to North America

SEOUL, South Korea, Oct. 20, 2025 -- WellsCare, a South Korean medical technology startup, announced that on October 9, it signed a Memorandum of Understanding (MOU) with Celltrion Canada, a subsidiary of the global biopharmaceutical leader Celltrion. This strategic partnership is set to enhance the development and distribution of advanced laser medical devices for pain management across North America. The collaboration will focus on the distribution of WellsCare's innovative home-use laser therapy device, IASO, which is designed for effective musculoskeletal pain relief. The I
- 김갑성 기자
- 2025-10-20 21:00
BTL's EMSCULPT NEO Used in Astronaut Training in Hungary for International Space Mission

PRAGUE, Oct. 20, 2025 -- BTL, a global leader in medical technologies, proudly announces that its flagship device, EMSCULPT NEO, played a key role in astronaut preparation ahead of a historic spaceflight. As a result of the cooperation between BTL Hungary and HUNOR (Hungarian To Orbit) program, EMSCULPT NEO was incorporated into Hungarian research astronaut Tibor Kapu's intensive pre-flight training program to prepare for his upcoming mission aboard the International Space Station (ISS). "Studies show astronauts lose up to 30% of muscle mass in or
- 김갑성 기자
- 2025-10-20 20:09
Weaving a Network of Care Together: Jiahui International Hospital (Shanghai) and NYU Shanghai Unveil Cooperative Program

SHANGHAI, Oct. 20, 2025 -- On the morning of Oct. 18, 2025, during Jiahui Health's Breast Cancer Awareness Month program, Jiahui International Hospital (Shanghai) was officially recognized as an internship site for the Social Work program at NYU Shanghai. John K. HSIANG, MD, PhD, chairman of the Jiahui Health Executive Committee, and Qingwen Xu, coordinator of the Global MSW Program and affiliated professor at NYU Shanghai, and professor of social work at NYU's Silver School of Social Work, unveiled the plaque. Nearly one hundred medical professionals and patients' families witnessed this mil
- 김갑성 기자
- 2025-10-20 20:03
Exploring the Next Era of Cell & Gene Therapy with Nobel Laureate in London

PISCATAWAY, N.J., Oct. 20, 2025 -- London will become the global spotlight for cell and gene therapy (CGT) this November as Nobel Laureate, scientific leaders, biotech innovators, and top investors convene to chart the future of one of the fastest-growing fields in emerging medicine. CGT is rapidly transforming the landscape of modern medicine, driving breakthroughs from laboratory research into real-world clinical applications. From genome editing to in vivo and ex vivo cell therapy platforms, CGT has become one of the most promising fields in life sciences, supported by rising global
- 김갑성 기자
- 2025-10-20 19:43
HanchorBio Showcases Pipeline Momentum with HCB101 and HCB301 Data Across Five Major Oncology Meetings in Q4 2025

[ 메디채널 김갑성 기자 ] Presentations highlight HCB101's differentiated profile and introduce first preclinical data from HCB301, underscoring HanchorBio's innovation in next-generation immunotherapies TAIPEI, SHANGHAI and SAN FRANCISCO, Oct. 20, 2025 -- HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company developing next-generation immunotherapies, today announced that new clinical data from HCB101, its differentiated, engineered SIRPα-Fc fusion protein, and the preclinical results from HCB301, its next-generation tri-specific checkpoint immunotherapy, will be present
- 김갑성 기자
- 2025-10-20 19:00

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2025-11-04_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 11월 04일 14시 40분